DE602005011468D1 - Gemeinsame gabe von tigecyclin und digoxin - Google Patents

Gemeinsame gabe von tigecyclin und digoxin

Info

Publication number
DE602005011468D1
DE602005011468D1 DE602005011468T DE602005011468T DE602005011468D1 DE 602005011468 D1 DE602005011468 D1 DE 602005011468D1 DE 602005011468 T DE602005011468 T DE 602005011468T DE 602005011468 T DE602005011468 T DE 602005011468T DE 602005011468 D1 DE602005011468 D1 DE 602005011468D1
Authority
DE
Germany
Prior art keywords
digoxin
tigecyclin
common gift
gift
common
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005011468T
Other languages
English (en)
Inventor
Donald G Raible
Gopal Muralidharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of DE602005011468D1 publication Critical patent/DE602005011468D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
DE602005011468T 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin Expired - Fee Related DE602005011468D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28
PCT/US2005/038410 WO2006060084A2 (en) 2004-10-28 2005-10-24 Coadministration of tigecycline and digoxin

Publications (1)

Publication Number Publication Date
DE602005011468D1 true DE602005011468D1 (de) 2009-01-15

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005011468T Expired - Fee Related DE602005011468D1 (de) 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (de)
EP (1) EP1804807B1 (de)
JP (1) JP2008518911A (de)
KR (1) KR20070069182A (de)
CN (1) CN101039679A (de)
AT (1) ATE415973T1 (de)
AU (1) AU2005310306A1 (de)
BR (1) BRPI0517406A (de)
CA (1) CA2582089A1 (de)
CR (1) CR9073A (de)
DE (1) DE602005011468D1 (de)
EC (1) ECSP077423A (de)
IL (1) IL182681A0 (de)
MX (1) MX2007005163A (de)
NO (1) NO20071706L (de)
RU (1) RU2007112409A (de)
WO (1) WO2006060084A2 (de)
ZA (1) ZA200703441B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1858488B2 (de) 2005-03-14 2022-07-20 Wyeth LLC Tigecyclin-zusammensetzungen und herstellungsverfahren dafür
PE20070072A1 (es) * 2005-06-16 2007-02-25 Wyeth Corp Proceso de manufactura para tigeciclina como polvo reconstituible
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
KR20230038601A (ko) 2017-01-27 2023-03-20 뉴로크린 바이오사이언시즈 인코퍼레이티드 특정 ｖｍａｔ2 억제제의 투여 방법
CA3076000A1 (en) 2017-09-21 2019-03-28 Neurocrine Biosciences, Inc. High dosage valbenazine formulation and compositions, methods, and kits related thereto
US20200230127A1 (en) * 2017-10-10 2020-07-23 Neurocrine Biosciences, Inc. Methods for the Administration of Certain VMAT2 Inhibitors

Also Published As

Publication number Publication date
KR20070069182A (ko) 2007-07-02
ZA200703441B (en) 2008-09-25
WO2006060084A2 (en) 2006-06-08
BRPI0517406A (pt) 2008-10-07
CA2582089A1 (en) 2006-06-08
CN101039679A (zh) 2007-09-19
RU2007112409A (ru) 2008-12-10
CR9073A (es) 2007-08-28
US20060094668A1 (en) 2006-05-04
EP1804807A2 (de) 2007-07-11
MX2007005163A (es) 2007-06-26
AU2005310306A1 (en) 2006-06-08
JP2008518911A (ja) 2008-06-05
EP1804807B1 (de) 2008-12-03
ECSP077423A (es) 2007-05-30
NO20071706L (no) 2007-05-24
ATE415973T1 (de) 2008-12-15
WO2006060084A3 (en) 2006-07-20
IL182681A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
DE602005011468D1 (de) Gemeinsame gabe von tigecyclin und digoxin
CY1119518T1 (el) Τροποποιημενα αντιγονα φυματιωσης
BR112013010857A2 (pt) imonoglubulinas de duplo domínio variável e usos das mesmas
CY1112912T1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
BR112013002578A2 (pt) imunoglobinas de domínio variável duplo e usos das mesmas
CL2012002326A1 (es) Uso de una combinación de por lo menos un agente quimioterapéutico y una cantidad efectiva de un anticuerpo anti-vegf (factor de crecimiento endotelial vascular), porque sirve para preparar un medicamento útil en el tratamiento de cáncer ovárico; y su kit para tratar el cáncer ovárico sin tratamiento anterior en una paciente humana.
RU2011115406A (ru) Новые пиримидиновые производные и их применение в терапии, а также применение пиримидиновых производных в изготовлении лекарственного средства для предупреждения и/или лечения болезни альцгеймера
ATE525070T1 (de) Silbininkomponente zur behandlung von hepatitis
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
EA201171186A1 (ru) Сокристалл этравирина и никотинамида
EA201891608A1 (ru) Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана
ATE468849T1 (de) Idebenon zur behandlung von muskeldystrophien
ITBS20040068A1 (it) Composizione cosmetica e/o farmaceutica per il trattamento della rosacea
ATE433459T1 (de) Desoxo-nonadepsipeptide
EA201891610A1 (ru) Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ATE455789T1 (de) Substituierte nonadepsipeptide
IT1396915B1 (it) Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv.
EA200602002A1 (ru) Применение спинозинов для заживления ран
DE502005001365D1 (de) Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und/oder Pelargonium Reniforme
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
WO2011106378A3 (en) Oral b12 therapy
ZA202300222B (en) Anti-αlpha-4-βeta-7 antibodies
UA110918C2 (uk) Інгібітори протеїнфосфатази-1 та їх застосування

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee